Morgan Stanley Armata Pharmaceuticals, Inc. Transaction History
Morgan Stanley
- $1.49 Trillion
- Q2 2025
A detailed history of Morgan Stanley transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 109 shares of ARMP stock, worth $377. This represents 0.0% of its overall portfolio holdings.
Number of Shares
109
Previous 109
-0.0%
Holding current value
$377
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ARMP
# of Institutions
28Shares Held
730KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA260KShares$899,8520.0% of portfolio
-
Geode Capital Management, LLC Boston, MA105KShares$361,7290.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$346,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX44.7KShares$154,5990.0% of portfolio
-
State Street Corp Boston, MA40.3KShares$139,4380.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $125M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...